The tumor suppressor ARF is transcribed from the INK4a/ ARF locus in partly overlapping reading frames with the CDK inhibitor p16
Ink4a
. ARF is able to antagonize the MDM2-mediated ubiquitination and degradation of p53, leading to either cell cycle arrest or apoptosis, depending on the cellular context. However, recent data point to additional p53-independent functions of mouse p19 ARF .
Little is known about the dependency of human p14 ARF function on p53 and its downstream genes. Therefore, we analysed the mechanism of p14 ARF -induced cell cycle arrest in several human cell types. Wild-type HCT116 colon carcinoma cells (p53 +/+ p21 CIP1+/+ 14-3-3s
), but not p53 7/7 counterparts, underwent G 1 and G 2 cell cycle arrest following infection with a p14 ARF -adenovirus. In p21 CIP17/7 cells, p14
ARF did not induce G 1 or G 2 arrest, while 14-3-3s
Introduction
The INK4a/ARF gene locus encodes for two cell cycle regulatory proteins, p16 Ink4a and ARF (alternative reading frame; human p14 ARF , murine p19 ARF ), in dierent, overlapping reading frames. The two transcripts have separate ®rst exons but share exons 2 and 3. Exon 2 is transcribed in distinct readings frames such that there is no amino acid homology between the two proteins (Chin et al., 1998b; Sharpless and DePinho, 1999) . p16 Ink4a belongs to the INK4 family of cyclindependent kinase (CDK) inhibitors and inhibits CDK 4 and 6 activities, thus leading to decreased phosphorylation of RB and to G 1 arrest. Cells that are de®cient for RB are resistant to p16
Ink4a -mediated cell cycle arrest (Sherr and Roberts, 1995; Weinberg, 1995) .
ARF is also a cell cyle inhibitor. It does not directly inhibit CDKs but interferes with the function of MDM2 to destabilize p53. ARF may be activated by aberrant activation of oncoproteins such as Ras , c-myc ), E1A (de Stanchina et al., 1998 , Abl (Radfar et al., 1998) and E2F-1 . In these scenarios, ARF is believed to counteract the oncogenic hyperproliferative eect, predominantly by induction of both G 1 and G 2 arrest (Quelle et al., 1995) .
Human p14 ARF is only 49% homologous to murine p19 ARF and 5 kDa smaller. Despite such high size and sequence divergence, p19 ARF and p14 ARF share similar properties. Both p19 ARF and p14 ARF can directly interact with MDM2 (Pomerantz et al., 1998; Zhang et al., 1998) . MDM2 binds to p53 leading to the ubiquitin-mediated degradation of p53. Since p53 transactivates MDM2, this constitutes a negative feedback loop between MDM2 and p53 . The interaction of ARF with MDM2 prevents the MDM2-mediated p53 degradation and subsequently leads to the stabilization and activation of p53, which then induces either cell cycle arrest or apoptosis, depending on the cellular context.
The INK4a/ARF gene locus is one of the most frequently targeted genes in human carcinogenesis. p16
Ink4a is a bona ®de tumor suppressor, showing frequent deletions, point mutations and hypermethylations exclusively targeting p16
Ink4a in many human cancers (Chin et al., 1998a; Sharpless and DePinho, 1999) . In contrast, the role of ARF in human carcinogenesis is less clear. Many deletions target not only p16
Ink4a , but also p14 ARF . However, there are few point mutations or deletions known so far to exclusively target p14 ARF (Chin et al., 1998b) , and most point mutations in exon 2 render p16 INK4A and not p14 ARF unfunctional in in vitro assays . On the other hand, the role of ARF as a tumor suppressor has been supported by a mouse model in which exon 1b has exclusively been disrupted (Kamijo et al., 1997) . The resulting p19 ARF null mice developed lymphomas and sarcomas at an early age, a phenotype very similar to that of INK4a/ARF exon 2 knockout mice, which lack both p19 ARF and p16
Ink4a (Serrano et al., 1996) . It is believed that the function of murine and human ARF to induce arrest mainly depends on the stabilization and activation of p53. However, the analysis of p19 ARF in mouse embryo ®broblasts (MEFs) has pointed to additional p53-independent mechanisms of p19 ARF function (Carnero et al., 2000; Weber et al., 2000) . Furthermore, little is known about the downstream eectors once p53 is activated by ARF. In general, it is believed that the p53 function to arrest the cell cycle, i.e. following DNA damage, depends primarily on the transactivation of speci®c p53-responsive genes, such as p21 CIP1 , 14-3-3s, and others. (Levine, 1997; Vogelstein et al., 2000; Vousden, 2000) . However, mouse p19
ARF may inhibit the cell cycle through both p21 CIP1 -dependent and p21 CIP1 -independent pathways (Modestou et al., 2001) .
Results
We set out to analyse the dependency of p14 ARFinduced cell cycle arrest on p53 and the p53 target genes, p21 CIP1 and 14-3-3s, in the human colorectal cancer cell line, HCT116. This cell line (p53
CIP1+/+ 14-3-3s +/+ ) and various isogenic knockout cell lines, derived from the parental HCT116 cells by homologous recombination (Waldman et al., 1995) , have been successfully used in a number of cell cycle studies (Bunz et al., 1998; Chan et al., 1999; McShea et al., 2000; Samuel et al., 2001; Waldman et al., 1996 Waldman et al., , 1997 . Their phenotype, mostly in the context of a DNA damage response, has been extensively documented. In HCT cells, the endogenous p14 ARF gene is silenced by mutation of one and methylation of the other allele, respectively (Burri et al., 2001) . Therefore, the introduction of p14 ARF into these cells substitutes missing p14
ARF expression instead of increasing already existing p14 ARF expression. The adenoviral pAdEasy system (He et al., 1998) was used to express p14 ARF in the cells. The newly generated adenovirus (ad-ARF) encoded for p14 ARF and the GFP gene under the control of two separated cytomegalovirus promotors. Therefore, the infected cells could be traced throughout the experiment. As a control, an adenovirus encoding for GFP only (ad-GFP) was used. GFP¯uorescence indicated that 100% of the target cells were infected (data not shown). To compare the activation of p53 in response to ARF with its activation by DNA damage, all cells were treated with adriamycin (ADR). We analysed the onset of ARF-mediated eects in a time frame of up to 48 h following infection.
Following infection with ad-ARF, the HCT cells showed a high level of ARF expression as early as 12 h post-infection, which was stable for at least another 36 h (data not shown). In the wild-type HCT cells, ad-ARF infection led to the stabilization of p53 and induction of the p53 targets MDM2, p21
CIP1 and 14-3-3s ( Figure 1 ). This coincided with the downregulation of CDK2 activity and the subsequent hypophosphorylation of RB, indicative of G 1 arrest. The CDK2 inhibition was mediated by p21 CIP1 , since p21 CIP1 was detected in anti-CDK2 immunoprecipitates both in the ad-ARF-infected and ADR-treated cells (data not shown). Consequently, the percentage of S phase cells, as evaluated by BrdU incorporation and¯ow cytometry analysis, was decreased ( Figure 1 ). In comparison, ADR-treated HCT cells showed a profound p53 induction and subsequent induction of p21 CIP1 and 14-3-3s with concomitant G 1 and G 2 cell cycle arrest.
CDK1/Cyclin B activity, the key regulatory CDK complex governing G 2 /M, was also markedly reduced both in ad-ARF-and ADR-treated wild-type cells, indicative of G 2 arrest. CDK1 activity is primarily regulated by activating and inhibitory phosphorylations. Therefore, the phosphorylation status of CDK1 was analysed by immunoblotting. Interestingly, CDK1 showed a hyperphosphorylated pattern, indicative of inhibitory tyrosine 14/threonine 15 phosphorylation (Herzinger et al., 1995) , only in ADR-treated cells but not in ad-ARF-infected cells (Figure 1 ).
The current model of ARF function involves the direct association of ARF and MDM2 leading to the inhibition of MDM2-mediated ubiquitination of p53 ARF (ad-ARF) was used to express p14 ARF in wild-type and p53 7/7 HCT116 cells. As a negative control an adenovirus encoding for GFP (ad-GFP) was used. Treatment with adriamycin (ADR) to induce DNA damage served as a control for the activation of p53. At 24 h posttreatment either BrdU-labeled cells were harvested for¯ow cytometry analysis and whole-cell extracts were made for analysis of the relevant cell cycle regulators by immunoblotting or determination of CDK activities Pomerantz et al., 1998; Stott et al., 1998; Zhang et al., 1998) ; however, the precise requirement of MDM2 relocation for p53 stabilization is under investigation (Korgaonkar et al., 2002; Llanos et al., 2001) . To verify the functionality of ARF in HCT cells, coimmuniprecipitation experiments were performed con®rming the binding of ARF to MDM2 (data not shown).
Next, the p53 7/7 cells were analysed in an identical manner. Ad-ARF infection of these cells did not lead to induction of MDM2, p21 CIP1 , or 14-3-3s. Importantly, there was no indication of cell cycle arrest as judged by BrdU incorporation, RB phosphorylation, and CDK2 as well as cyclin B-associated kinase activities (Figure 1) .
Since p21 CIP1 and 14-3-3s are key mediators of p53-induced G 1 and G 2 arrest, respectively, we then analysed single p21 CIP17/7 and 14-3-3s 7/7 cells as well as cells with combined de®ciency for p21 CIP1 and 14-3-3s. Ad-ARF infection of p21 CIP17/7 cells led to p53 induction with concomitant increase of MDM2 and 14-3-3s proteins (Figure 2 ), comparable to wild-type HCT cells. Strinkingly, no signi®cant change in BrdU incorporation, RB phosphorylation, and CDK2 as well as cyclin B-associated kinase activities was observed, suggesting a central role of p21 CIP1 in mediating G 1 and G 2 arrest following p14 ARF -infection. In 14-3-3s 7/7 cells, p14 ARF infection led to decreased CDK2 activity and hypophosphorylation of RB coinciding with p21 induction. However, cyclin Bassociated kinase activity was only marginally altered, suggesting that 14-3-3s is dispensable for p14 ARF -induced G 1 but important for G 2 arrest. Importantly, p21 CIP17/7 14-3-3s 7/7 cells showed identical resistance to the ad-ARF infection as the p53 7/7 cells ( Figure 2 ). All cell types in this scenario did not undergo apoptosis during the time frame of the analysis.
To con®rm these results using another expression system, these experiments were also performed with a high-titer, pantropic retrovirus encoding for p14 ARF . Compared to the ad-ARF infection experiments, identical results were achieved by infecting the cells with the p14 ARF retrovirus (data not shown). p14 ARF eects were then analysed in the human embryo kidney cell line 293. 293 cells have been transformed by adenovirus E1A and E1B oncogenes, which has led to the inactivation of p53 and RB. To analyse p14
ARF -mediated eects in this cell line we established an inducible system based on an ecdysoneinducible receptor This receptor is only activated in the presence of the hormone ecdysone or the ecdysone homologue ponasterone A leading to transactivation of the inserted gene.
Following induction by ecdysone, p14 ARF protein level rised as early as 9 h and persisted for at least 48 h (Figure 3a) . Immuno¯uorescence analysis showed that 100% of the ecdysone-treated cells were induced to express p14 ARF , located to the nucleoli, whereas untreated cells showed low p14 ARF expression. No cell cycle arrest in the ecdysone-treated 293 cells was observed as measured by BrdU incorporation ( Figure  3a) . No dierence in the expression pattern of the relevant cell cycle regulators was seen. Importantly, CDK2 activity as well as cyclin B-associated kinase activity remained unchanged (Figure 3a) . Figure 2 p14 ARF -induced G 1 and G 2 arrest depends on the p53-responsive genes p21 and 14-3-3s, respectively. An adenovirus encoding for p14 ARF (ad-ARF) was used to express p14 ARF in p21 CIP17/7 , 14-3-3s
, and p21 CIP17/7 14-3-3s 7/7 HCT cells. Identical analyses were performed as in Figure 1 Furthermore, the association of p14 ARF and MDM2 was analysed under these conditions as an indication of ARF functionality. Immunoprecipitation experiments with anti-ARF and anti-MDM2 antibodies con®rmed the binding of p14 ARF to MDM2 and vice versa ( Figure  3b ). Note that anti-ARF immunoprecipitates contained MDM2 protein already in the absence of ecdysone as a consequence of basal ARF expression.
Genetic instability in cell lines might lead to alterations of central signaling pathways. To exclude such alterations as a cause of an impaired cell cycle response, p14 ARF -induced cell cycle arrest was also analysed in human primary foreskin keratinocytes (HFKs). Following infection of the HFKs with ad-ARF, induction of p53, MDM2 and p21 as well as concomitant G 1 cell cycle arrest as judged by BrdU incorporation and the hypophosphorylation of RB were detected (data not shown). In HFKs stably retrovirally transduced with the human papillomavirus type 16 E6 oncoprotein, which destabilizes p53, the ad-ARF infection did not lead to induction of p53 and p21 CIP1 , and there was no evidence of cell cycle arrest.
Discussion
The majority of work dealing with ARF function was done in rodent cells with dierent genetic backgrounds. Wild-type MEFs showed a decrease in the S phase population 48 h following p19 ARF retroviral infection, in contrast to MEFs with sustained p53 mutations or the p53-negative Balb 3T3 cells (Kamijo et al., 1997) . Similarly, p53 7/7 MEFs were not arrested by a p19 ARF -retrovirus (Modestou et al., 2001) . In cotransformation assays, foci formation of wild-type rat embryo ®broblasts (REFs) by Myc and Ras was inhibited by cotransfection of p19 ARF (Pomerantz et al., 1998) . In contrast, the foci formation of REFs redendered p53-de®cient by either a dominant negative p53-construct or the SV40 large T antigen was not inhibited by p19 ARF (Pomerantz et al., 1998) . Whereas these studies demonstrated a p53 dependency of p19 ARF , recent data provide evidence for p53-independent functions in MEFs lacking not only p53 but also MDM2 (Weber et al., 2000) . p53
MEFs showed a decrease of BrdU positive cells following p19 ARF retroviral infection, with a minimum of labeled cells at 96 h post-infection, the mechanisms of which are unknown. In another study, CRE recombinase excisable p19 ARF antisense constructs were used to decrease the endogenous p19 ARF expression level in MEFs. Immortalization both in a p53-dependent and p53-independent manner following excision of the p19 ARF antisense constructs was shown (Carnero et al., 2000) . In addition, the mechanism of p53-mediated cell cycle arrest once p53 is activated by p19 ARF is unclear. p53 7/7 MEFs were not arrested by p19 ARF . In contrast, p21 CIP17/7 MEFs underwent p19 ARF -induced G 1 and G 2 arrest, suggesting p53-dependent, p21-independent mechanisms (Modestou et al., 2001) . To this end, the exact nature of these mechanisms has remained elusive.
In light of these partially contradictory data, we aimed to investigate the dependency of human p14 ARF on p53. The p53 7/7 cells showed a complete defect in their G 1 and G 2 arrest response to p14 ARF -infection. Moreover, p21 CIP17/7 cells were resistant to p14 ARFinduced G 1 and G 2 arrest. Intriguingly, this further underscores that p21 CIP1 functions as a central regulator both in G 1 (Samuel et al., 2001; Waldman et al., 1995) and G 2 (Bunz et al., 1998; McShea et al., 2000; Waldman et al., 1996) by diverse mechanisms. On the contrary, 14-3-3s 7/7 cells showed only incomplete arrest in G 2 following ARF infection, pointing to at least a partial function of 14-3-3s in G 2 (Chan et al., 1999; Hermeking et al., 1997; Samuel et al., 2001) , also after ARF infection. Importantly, p21 CIP17/7 14-3-3s 7/7 cells behaved identical to the p53 7/7 cells. This underscores the dependency of human p14
ARF on the p53 pathway and suggests cooperative functions of p21 CIP1 and 14-3-3s in mediating p14
ARF -induced G 2 arrest. Furthermore, these two p53-regulated genes appear to be predominantly responsible for ARF-induced cell cycle arrest, which diers from the DNA damage-induced arrest.
Few investigations have dealt with the pathway utilized by human p14
ARF . The osteosarcoma cell line U2OS and the breast cancer cell line MCF7, both containing wild-type p53 and RB, were arrested 48 h following exogenous p14 ARF expression . In comparison, the osteosarcoma cell line SAOS2, which is defective for both p53 and RB function, and the p53-negative lung carcinoma cell line H1299 were not arrested by p14 ARF . In line with these results, replicative and p14 ARF -induced senescence in human ®broblast strains was recently shown to depend on the presence of p21 CIP1 (Wei et al., 2001) . In contrast, p14 ARF transfection of SAOS2 cells and the p53-negative human bronchioalveolar carcinoma cell line H358 followed by selection led to a decrease in the number of surviving cells, as compared to emptyvector transfection (Eymin et al., 2001) . This approach was used as to determine ARF-dependent long-term eects. In the latter study, p14
ARF was found to interact with E2F1 thereby inhibiting its transcriptional activity; however, the functional role and importance of this interaction remains to be elucidated.
Taken together, the existing data point to dierent mechanisms as to how ARF inhibits cellular proliferation. Mouse p19 ARF appears to induce arrest in both a p53-dependent and -independent manner, while human p14 ARF acts in a p53-dependent manner. Most experiments showing a p53 dependency of p19 ARFinduced arrest were done in a 24 ± 48 h-time frame (Kamijo et al., 1997; Modestou et al., 2001) . However, once activated over a longer time period ARF might be able to induce arrest or apoptosis in a p53-negative background (Carnero et al., 2000; Eymin et al., 2001; Weber et al., 2000) , the mechanisms of which are poorly understood. In conclusion, we demonstrate here that the onset of p14 ARF -mediated G 1 and G 2 arrest in epithelial cells strictly depends on the p53 pathway and the downstream genes, p21
CIP1 and 14-3-3s.
Materials and methods

Cell lines and transfections
HCT116 and various knockout clones of HCT116 derived by homologous recombination were a generous gift from B Vogelstein and H Hermeking, and cultured as described (Bunz et al., 1998; Chan et al., 1999; Waldman et al., 1995) . In each case two independently derived knockout clones were used. Transient transfections were made using lipofectamine (Gibco) according to standard protocols.
Generation of adenoviruses and retroviruses
Full-length p14 ARF generated by PCR was subcloned into pAdTrack-CMV (Qbiogene). Recombination with the pAdEasy vector (provided by B Vogelstein; He et al., 1998) containing the adenoviral genes was performed in bacteria as described. The resulting plasmid was then transfected into 293 cells to produce the complete Ad-ARF adenovirus. The MOI to reach 100% of the cells was optimized by counting GFP-positive cells. LXSN-ARF was a gift from Jennifer Benanti and Denise A Galloway. LXSN retroviruses and generation of packaging cells have been described (Funk et al., 1997) . The env protein of this retrovirus has been changed to the VSVg protein which mediates viral entry through lipid binding and plasma membrane fusion. High titer virus was produced by ultracentrifugation.
Ecdysone-inducible system
In 293 cells, an ecdysone-inducible system was established according to the manufacturer's instructions (Invitrogen). Following cloning of the p14 ARF gene into the pIND inducible expression vector the resulting pIND-ARF was stably transfected into EcR-293 cells that already expressed the functional ecdysone receptor from pVgRXR.
Immunoblotting, immunoprecipitations, and kinase assays
These analyses were performed as described previously (Funk et al., 1997; Herzinger et al., 1995; Samuel et al., 2001 ). Whole-cell lysates were prepared by brief sonication in lysis buer containing 50 mM HEPES pH 7.5, 450 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 10 % glycerol, 1 mM NaF, 0.1 mM sodium orthovanadate, 10 mM beta-glycerophosphate and 0.1% Tween 20. For Immunoblotting, 20 mg of wholecell extract were loaded. Immunoprecipitations were carried out using 200 or 1500 mg whole cell extract and band intensity compared to the signal obtained from 20 mg of crude extract.
Antibodies
Antibodies were sourced as follows: anti-cdc2, anti-p21, antip53 (Oncogene Science), anti-cyclin B1 (Pharmingen, GNS-1), anti-p21 (C-19), anti-CDK2, anti-MDM2 (Santa Cruz), anti-RB (Becton-Dickinson). Anti-14-3-3s was a gift from H Hermeking (Chan et al., 1999) . A polyclonal antibody against a C-terminal p14 ARF peptide was generated in rabbits. To test this antibody, a pCMV vector encoding for the human p14 ARF protein was transfected into HCT cells. p14 ARF was detected in immunoblots of transfected cell extracts, and the C-terminal p14 ARF peptide blocked this reactivity (data not shown).
FACS analysis
Samples were ®xed in 70% ethanol in PBS after BrdU labeling according to Funk et al. (1997) , stained with 50 mg/ ml Pl and analysed on a Becton Dickinson FacScan II.
